Enrollment in clinical trials is crucialto continued scientific discovery andimproved patient care.
David Dorr, MD, MS
Advertisement
Articles by David Dorr, MD, MS
Advertisement
Latest Updated Articles
- Reporting Only ‘Unanticipated’ AEs of Trial Drugs Would Reduce IRB Workload, But Would Patient Safety Suffer?
Published: November 1st 2006 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
ASH 2025: Key Anticipated Updates in the Leukemia Landscape
2
ASH 2025: Which Presentations Will Move the Multiple Myeloma Needle?
3
Real-World Elranatamab Maintains Responses in Elderly, Frail R/R Multiple Myeloma
4
Fixed-Duration Venetoclax Combos Show Noninferior PFS to Ibrutinib in CLL
5
